Report Scope: This report aims to provide a comprehensive study of the global market for neurostimulation technologies/devices. It provides a detailed description of the different types of neurostimulation technologies/devices (invasive and noninvasive) and their current and historical market revenues.
Neurostimulation technologies/devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.
This report also covers a detailed study of therapeutic applications of neurostimulation technologies/devices including chronic pain, Parkinson’s disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies/devices includes historical data and market projection on sales by, device type, therapeutic applications and region.
For in-depth understanding of the market, profiles of market participants, key marketed devices, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global neurostimulation technology/devices market.
Report Includes: - 21 data tables and 20 additional tables - An overview of the global markets and technologies for neurostimulation - Estimation of the market size and analyses of market trends, with data from 2020, estimates for 2021 and projection of CAGR through 2026 - Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases - Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies - Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies - Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth - Details about symptoms, progression and epidemiology of COVID-19 and discussion on impact of COVID-19 pandemic on medical industry as well as on neurostimulation market - Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies - Comprehensive company profiles of major players of the industry, including Abbott Laboratories, Boston Scientific, Medtronic PLC, NeuroMetrix, NeuroSigma and Soterix Medical Inc.
Summary: The human nervous system works as the head commander of the human body and medical science community have long believed that it has huge potential in treatment of human body disorders.
Neurostimulation technology involves alteration or modulation of nerves. Neurostimulation devices deliver electrical current or magnetic impulses directly to nerves to modify their activities.
In the last 25-30 years, neurostimulation has emerged as one of the most dynamic and exciting therapy field that has been actively investigated for treatment of a range of clinical conditions including chronic pain, movement disorders (Parkinson’s disease, tremor, dystonia and others), epilepsy, psychiatric disorders, functional restoration, cardiovascular disorders, gastrointestinal disorders and genitourinary disorders. It is also referred as “drug-free solutions.” Currently, the potential of neurostimulation technology is actively being explored in several other clinical conditions including obesity, tinnitus and central nerve system disorders.
Given the vast size of the potential treatment population and ongoing scientific discoveries and technological advances in neurostimulation technologies, the neurostimulation devices’ market is poised for significant growth.For example, according to the WHO, epilepsy is one of the most common neurological diseases globally, affecting around 50 million people around the world.
According to the CDC, an estimated 50 million adults suffered from chronic pain in the U.S. in 2016, including 19.6 million adults who had high-impact chronic pain. Moreover, with growing geriatric populations and increasing trend toward the use of nondrug therapies, greater expectations for quality of life, and improved patient attitudes toward receiving medical attention, the neurostimulation technology market is expected to grow significantly in coming years.
The global neurostimulation device market is estimated to have been worth nearly REDACTED in 2020.Between 2021 and 2026, the market is predicted to see a compound annual growth rate (CAGR) of REDACTED, leading to a market value of REDACTED in 2026.
This market is experiencing significant growth, largely driven by favorable demographic trends, focus on reducing opioid usage and product innovations.
Our reports have been used by over 10K customers, including:
Europe specialty generics market reached a value of US$ 16.4 Billion in 2020. Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
KEY FINDINGS The global cartilage repair market is projected to record a CAGR of 15.42% during the forecast period, 2021-2028. The factors fueling the market growth are the rising geriatric population, the increasing sports injuries, and the growing prevalence of obesity. MARKET INSIGHTS Cartilage...
KEY FINDINGS The global cleanroom consumables market is set to project a CAGR of 9.17% during the forecast period, 2021-2028. The growing need for quality products in the manufacturing industries, strict cleanroom regulations and standards, and thriving healthcare & biotechnology industries, drive market growth. MARKET...
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations...
Report Scope The report analyzes the market trends of Minoxidil with data from 2019, estimates from 2020, and projections of compound annual growth rates (CAGRs) through the forecast period of 2020 through 2025). The report will highlight the current and future market potential of Minoxidil along with an analysis of the...
120 pages •
By Infiniti Research Limited
• May 2021
Global Snoring Control Devices Market 2021-2025 The analyst has been monitoring the snoring control devices market and it is poised to grow by $ 323.25 million during 2021-2025, progressing at a CAGR of over 5% during the forecast period. Our report on snoring control devices market provides a holistic analysis, market...
175 pages •
By The Business Research Company
• May 2021
Major players in the wearable injectors market are Amgen, Becton, Dickinson and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, West Pharmaceutical Services,and Sensile Medical AG. The global wearable injectors market is expected to grow from $5.145 billion in 2020 to $5.709 billion...
Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 Summary Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Anemia of Chronic Disease pipeline landscape. The report provides comprehensive information...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.